Vykat Xr Tablet, Film Coated
Product Images NDC 83860-075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vykat Xr (NDC 83860-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Soleno Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Label (150mg)

FDA Label Image

Image Of Label (25mg)

Image Of Label (25mg)
This text contains information about a medication with NDC 83860-025-01, which is a extended-release tablets called Vykati'xr (diazoxide choline). It instructs to dispense the accompanying Medication Guide for each patient. The text also mentions something related to "30 tablets." This text provides details about the medication, dosing instructions, and possibly package size.*
FDA Label Image

Image Of Label (75mg)

Image Of Label (75mg)
This text provides the National Drug Code (NDC) for a medication called "vykat'xr" with the active ingredient diazoxide choline in extended-release tablets. It also instructs to dispense the accompanying Medication Guide to each patient. The prescription is for 30 tablets of SOLENS.*
FDA Label Image

Chemical Structure (Vykat Xr Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.